MetaCap

DataMeds AI Earnings

NASDAQ: MEDSHealth CareOther PharmaceuticalsUSD

1.34+0.6123 (+84.14%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

DataMeds AI earnings summary

In its most recent report on Nov 18, 2026 (Sep/2026), MEDS posted EPS of $2.72. Revenue for the quarter was $2.7 million. Quarterly EPS is down 90.2% from the same quarter a year earlier.

Summary generated from market data by MetaCap's automated system. Methodology

MEDS earnings history

DataMeds AI reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 18, 2026—$2.72——
Nov 13, 2026—$-1.18—+80.1%
Aug 17, 2026—$-7.13——
May 19, 2026—$-0.07——
Mar 20, 2026—$27.66——
Nov 19, 2025—$-23.07——
Aug 19, 2025—$-5.40——
May 12, 2025—$-0.62——
Mar 25, 2025—$-0.10——

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related